Clinical trials
Recruiting Respiratory Tract Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ArriVent BioPharma, Inc. | 1 |
| AstraZeneca | 1 |
| Eli Lilly and Company | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| The First Affiliated Hospital of Guangzhou Medical University | 1 |
| Turning Point Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 6 |
| Respiratory Tract Neoplasms | 6 |
| Bronchial Neoplasms | 5 |
| Lung Diseases | 5 |
| Neoplasms | 5 |
| Neoplasms by Site | 5 |
| Respiratory Tract Diseases | 5 |
| Thoracic Neoplasms | 5 |
| Carcinoma, Bronchogenic | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.